-
Pentoxifylline, TLR4, and Preterm Monocyte Inflammation
2026-08-17
The reference study shows that pentoxifylline suppresses LPS-driven inflammation in monocytes from preterm and term infants as well as adults, with particularly strong effects on selected preterm-cell markers. By combining flow cytometry, cytokine analysis, phagocytosis assays, and TLR4 transcript measurements, the work links altered monocyte phenotype to reduced TLR4 signaling and provides a useful in vitro framework for neonatal sepsis research.
-
Amiloride (MK-870) in Cell Assays
2026-08-17
This scenario-based guide explains how Amiloride (MK-870), SKU BA2768, can be integrated into cell viability, ion-transport, and endocytosis experiments without confusing pathway modulation with nonspecific cytotoxicity. It combines product-handling data with evidence from a reovirus entry study to support better controls, interpretation, and reagent selection.
-
Ruxolitinib Workflows for JAK1/2 Research
2026-08-16
Ruxolitinib (INCB018424) provides a practical way to interrogate JAK1/JAK2-dependent signaling, hematopoietic progenitor growth, and tumor immune remodeling. This guide connects phospho-signaling assays and colony workflows with high-dimensional immune profiling, including the combination of Ruxolitinib and oncolytic HSV in a murine sarcoma model.
-
HCAR3 Agonist Selectivity: Cryo-EM Insights
2026-08-15
Ye et al. resolve cryo-EM structures of HCAR3 and HCAR2 bound to selective agonists, including Acifran, and identify receptor-pocket features that govern ligand recognition and selectivity. The findings connect structural differences to cAMP signaling and provide a mechanistic framework for developing HCAR3-directed approaches to lipid and metabolic disorder research.
-
Tropisetron Hydrochloride: Assay Workflows
2026-08-14
Build cleaner serotonin receptor signaling research by pairing Tropisetron Hydrochloride with receptor-response assays and transporter-aware controls. This workflow also translates renal OCT2/MATE1 findings into practical cell-based experiments while separating 5-HT3 antagonism from α7-nicotinic receptor activity.
-
Cyclic di-GMP Workflows for Biofilms and STING
2026-08-14
Cyclic di-GMP supports two complementary research paths: mechanistic biofilm formation regulation and STING-centered immune modulation research. This workflow-focused guide covers aqueous handling, assay design, translational applications, and troubleshooting for bacterial persistence and cancer immunotherapy studies.
-
Multiple Myeloma Cell Lines: Mutations and Drug Resistance
2026-08-13
This study provides a comprehensive whole-exome view of 30 human multiple myeloma cell lines, identifying recurrent mutations, altered pathways, and genomic features associated with drug response. Its main practical contribution is a molecular framework for selecting cell models and interpreting resistance experiments in hematological malignancy research.
-
Acifran and the New Logic of HCAR Ligand Selectivity
2026-08-13
Acifran is more than a conventional HCAR agonist: recent cryo-EM evidence positions it as a valuable comparative probe for understanding HCAR2/GPR109A and HCAR3/GPR109B ligand recognition. This thought-leadership guide connects receptor structure, functional assay design, reagent handling, and translational strategy for lipid metabolism and metabolic disorder research.
-
ERK5 and ERK1/2 in Vitamin D–Driven AML Differentiation
2026-08-12
The reference study distinguishes the roles of the ERK5 and ERK1/2 branches of MAPK signaling during 1α,25-(OH)2 vitamin D3-induced differentiation of acute myeloid leukemia cells. Its key contribution is showing that pharmacological ERK5 inhibition can enhance myeloid marker expression while producing cell-cycle arrest, whereas MEK1/2–ERK1/2 inhibition with PD98059 or U0126 suppresses differentiation markers.
-
Cisapride in Cardiac Electrophysiology Research
2026-08-12
Cisapride (R 51619) provides a practical dual-mechanism probe for connecting 5-HT4 receptor signaling with hERG-associated electrophysiological liabilities. This guide shows how to deploy it in iPSC-cardiomyocyte imaging, electrophysiology, and deep-learning workflows while avoiding common concentration, solubility, and assay-interpretation errors.
-
Ruxolitinib Phosphate: JAK/STAT to ATC
2026-08-11
Ruxolitinib phosphate (INCB018424) offers a mechanistic route from JAK1/2 inhibition to mitochondrial cell-death analysis. This article translates recent anaplastic thyroid carcinoma findings into practical assay and experimental-design decisions.
-
KAS-ATAC: Mapping Accessible ssDNA in Chromatin
2026-08-11
The KAS-ATAC protocol combines ATAC-seq transposition with N3-kethoxal labeling to identify genomic fragments that are both physically accessible and contain single-stranded DNA. The approach helps distinguish open regulatory chromatin from accessible DNA engaged in transcription or other ssDNA-generating processes, while providing a practical workflow for labeling, enrichment, library construction, and data processing.
-
Z-VAD-FMK in Apoptosis and ZBP1 Death Assays
2026-08-10
Use Z-VAD-FMK to separate caspase-dependent apoptosis from alternative cell-death programs in cancer, immune-cell, and spliceosome-perturbation assays. This guide combines practical dosing logic, orthogonal readouts, and troubleshooting for studies inspired by recent Z-RNA and ZBP1 findings.
-
Mouse Tissue Lysis Kit (K1038) Workflow
2026-08-09
The Mouse Tissue Lysis Kit (K1038) provides a direct route from mouse tissue digestion to PCR-based genotyping by producing a lysate that can be used without additional DNA extraction or purification. It is intended for research workflows such as molecular biology and DNA analysis, not diagnostic or medical testing, and assay-specific validation remains necessary.
-
Chloramphenicol for Plasmid Selection
2026-08-08
Build cleaner plasmid selection assays with a defined 50S-ribosome mechanism, marker-aware dosing, and storage guidance. This workflow also shows how chloramphenicol selection can complement plasmid curing, PCR, conjugation, and transmission studies without confusing maintenance selection with resistance-gene detection.